roluperidone — Topline data
H2 2027
Topline data from Phase A of the trial is expected in the second half of 2027.Source filing
NERV biotech catalysts & pipeline
MINERVA NEUROSCIENCES INC · Data as of 2026-09-08
Upcoming catalysts
roluperidone — Topline data
2H 2028
The topline data from Phase B is expected in 2H 2028.Source filing